Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Genzyme Halts Development of New Kidney Drug; A “Very Significant” Bust, Analyst Says
|
Luke Timmerman |
11/18/09 |
Boston
|
|
Alkermes to Seek FDA Approval of Anti-Addiction Drug
|
Ryan McBride |
11/16/09 |
Boston
|
|
Ironwood, Forest Labs Drug for Chronic Constipation Passes Two Pivotal Trials
|
Luke Timmerman |
11/03/09 |
Boston
|
|
Vertex Hepatitis C Drug Wipes Out Virus For Toughest-to-Treat Patients
|
Luke Timmerman |
10/28/09 |
Boston
|
|
Zymo Gets $70M for Starting Trial
|
Luke Timmerman |
10/27/09 |
Seattle
|
|
Seattle Genetics Shares Drop on Halted Lymphoma Trial
|
Luke Timmerman |
10/05/09 |
Seattle
|
|
ZymoGenetics Partner Halts Multiple Sclerosis Trials After Drug Fails
|
Luke Timmerman |
09/28/09 |
Seattle
|
|
Zymo Drug Fails Arthritis Trials
|
Luke Timmerman |
09/10/09 |
Seattle
|
|
Acadia Takes a Fall, CareFusion Spins Off, Life Technologies Takes $450M in Cash, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
09/03/09 |
San Diego
|
|
Acadia Pharma Shares Crash After Lead Parkinson’s Drug Fails in Trial
|
Ryan McBride |
09/01/09 |
San Diego
|
|
Resolvyx, Swinging for the Fence in First Human Study, Passes Test with Drug for Dry Eye
|
Luke Timmerman |
08/24/09 |
Boston
|
|
Rib-X Antibiotic Passes Clinical Trial, Hopes to Snag Partner
|
Luke Timmerman |
08/05/09 |
Boston
|
|
Shire’s Gaucher Drug Passes Key Trial, Putting More Heat on Genzyme During Shortage
|
Luke Timmerman |
08/03/09 |
Boston
|
|
Oncothyreon Shows Long-Lasting Effect
|
Luke Timmerman |
08/03/09 |
Seattle
|
|
Anadys Cleared to Start HepC Trial
|
Luke Timmerman |
07/30/09 |
San Diego
|
|
$50M for Helicon, Cytori Bulks Up, Avanir Awaits Trial Results, & More San Diego Life Sciences News
|
Eric Hal Schwartz |
07/30/09 |
San Diego
|
|
Ariad Shares Boom as Cancer Drug Shows Promise
|
Luke Timmerman |
07/28/09 |
Boston
|
|
No More Tears: Avanir Investors Await Trial Results on Emotional Outburst Drug
|
Denise Gellene |
07/23/09 |
San Diego
|
|
Orexigen Obesity Drug Hits Weight Loss Goal in Studies, Company Looks Toward FDA
|
Luke Timmerman |
07/20/09 |
San Diego
|
|
Vical Encouraged by CMV Study
|
Denise Gellene |
07/08/09 |
San Diego
|
|
West Wireless Health Institute Discloses First Clinical Trial
|
Bruce V. Bigelow |
06/24/09 |
San Diego
|
|
Oncothyreon Drug Enters Pivotal Trial
|
Luke Timmerman |
06/22/09 |
Seattle
|
|
Seattle Genetics Starts New Trial
|
Luke Timmerman |
06/18/09 |
Seattle
|
|
Trius, Developer of Antibiotic for Deadly MRSA Bacteria, Passes Key Test
|
Luke Timmerman |
06/08/09 |
San Diego
|
|
Calistoga Drug Shrinks Tumors as Study Grows
|
Luke Timmerman |
06/06/09 |
Seattle
|
|
Arena Obesity Drug Helps Patients Shed a Few Pounds, Lower Risk of Heart Disease
|
Luke Timmerman |
06/06/09 |
San Diego
|
|
Orexigen Obesity Drug Produces “Modest” Weight Loss, Lowers Cardiovascular Risk
|
Luke Timmerman |
06/06/09 |
San Diego
|
|
Cell Therapeutics Lymphoma Drug Boosts Remissions, Shares Boom
|
Luke Timmerman |
06/01/09 |
Seattle
|
|
Alder Drug Fights Cancer Fatigue
|
Luke Timmerman |
06/01/09 |
Seattle
|
|
Aveo Kidney Cancer Drug, Challenging Pfizer and Bayer, Passes Important Test
|
Luke Timmerman |
05/29/09 |
Boston
|
|
Page 1 of
4 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
